GSC2 Activators
GSC2 activators are chemical entities designed to enhance the activity of the enzyme glucosylceramide synthase 2 (GSC2). Unlike inhibitors that aim to reduce or halt the enzyme's function, activators bind to GSC2 in a manner that increases its catalytic efficiency or stabilizes its active form. The biochemical pathway that GSC2 is a part of is integral to the synthesis of glycosphingolipids, complex molecules that are vital for the structural integrity and functionality of cellular membranes, as well as for modulating a myriad of cellular events. By increasing the activity of GSC2, these activators can potentially affect the levels of glycosphingolipids within the cell. The precise mechanism by which GSC2 activators exert their effect can vary; some may directly interact with the catalytic domain of the enzyme, thereby enhancing its natural substrate affinity or turnover rate, while others might bind to regulatory sites, inducing a conformational change that results in an upregulated enzymatic action.
The discovery and refinement of GSC2 activators involve a sophisticated understanding of the enzyme's structure and kinetics. Research initiatives often deploy a combination of empirical and in silico approaches to identify and optimize compounds that can positively interact with GSC2. Techniques such as computational chemistry and molecular dynamics simulations can predict how a molecule might interact with the enzyme, suggesting modifications that can improve efficacy or specificity. In parallel, laboratory techniques like site-directed mutagenesis, kinetic assays, and ligand-binding studies provide tangible insights into the activator-enzyme interaction. GSC2 activators are typically characterized by their ability to bind to the enzyme without initiating a denaturing effect, thus maintaining the enzyme's integrity while promoting its activity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts as a ligand for retinoic acid receptors, which regulate gene expression including genes that can influence the development pathways wherein GSC2 is implicated. By modulating gene expression, retinoic acid can indirectly upregulate GSC2 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular levels of cAMP. This can lead to activation of cAMP response element-binding protein (CREB), which may enhance the transcription of GSC2 as part of its wide range of target genes involved in cellular growth and differentiation pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to affect a multitude of signaling pathways, including those linked to cellular differentiation. It can potentially influence the expression of homeobox genes such as GSC2 by modulating these pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3, through its active metabolite calcitriol, binds to the vitamin D receptor (VDR) and regulates the expression of genes involved in development. VDR can interact with promoter regions of genes like GSC2, potentially increasing its expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, which can result in the stabilization and accumulation of β-catenin, a molecule that, upon entering the nucleus, can affect the transcription of various genes, potentially including GSC2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that can permeate cell membranes and activate PKA. This activation can result in the phosphorylation of transcription factors that influence gene expression, potentially affecting GSC2 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can affect chromatin structure and gene expression. By altering the acetylation status of histones, it can modulate the transcription of genes, possibly including those influencing GSC2 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is another HDAC inhibitor that can lead to hyperacetylation of histones and activation of gene transcription, which could include upregulation of GSC2. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
Folate is critical for the methylation of DNA, which can regulate gene expression. Adequate folate levels ensure proper gene methylation patterns, which could affect the expression of developmental genes like GSC2. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is an HDAC inhibitor that can induce the hyperacetylation of histones, affecting gene expression profiles in a manner that might upregulate genes like GSC2. | ||||||